TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW 14
1.4 CURRENCY AND PRICING 15
1.5 LIMITATIONS 15
1.6 MARKETS COVERED 16
2 MARKET SEGMENTATION 17
2.1 MARKETS COVERED 17
2.2 GEOGRAPHICAL SCOPE 18
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 DBMR TRIPOD DATA VALIDATION MODEL 19
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.6 MULTIVARIATE MODELLING 23
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE 23
2.8 MARKET APPLICATION COVERAGE GRID 24
2.9 DBMR MARKET POSITION GRID 25
2.10 VENDOR SHARE ANALYSIS 26
2.11 SECONDARY SOURCES 27
2.12 ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 30
4.1 PESTEL ANALYSIS 31
4.2 PORTER'S FIVE FORCES MODEL 32
5 ASIA-PACIFIC TOPICAL SKIN ADHESIVE MARKET, INDUSTRY INSIGHTS 33
6 REGULATORY FRAMEWORK 35
6.1 REGULATORY SCENARIO BY FDA 35
6.2 REGULATORY SCENARIO IN JAPAN 35
6.3 REGULATORY SCENARIO IN AUSTRALIA 35
6.4 REGULATORY SCENARIO IN CHINA 36
6.5 REGULATORY SCENARIO IN SINGAPORE 36
6.6 REGULATORY SCENARIO IN MALAYSIA 36
7 MARKET OVERVIEW 37
7.1 DRIVERS 39
7.1.1 RISING INCIDENCE OF BURN INJURIES AND SKIN DISEASES 39
7.1.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE 39
7.1.3 PENETRATION OF NEW TECHNOLOGIES 39
7.2 RESTRAINTS 40
7.2.1 LACK OF STANDARD REGULATORY GUIDELINES AND NON-FAVOURABLE REIMBURSEMENT SCENARIO 40
7.2.2 CHANGE IN CONSUMER PREFERENCE TOWARDS COST-EFFECTIVE ALTERNATIVES 40
7.3 OPPORTUNITIES 40
7.3.1 FASTER RECOVERY AND RESTORATION 40
7.3.2 STRATEGIC INITIATIVES BY GOVERNMENT AND MARKET PLAYERS 41
7.4 CHALLENGES 42
7.4.1 STRINGENT REGULATIONS 42
7.4.2 LACK OF TRAINING OR UNTRAINED STAFF 42
8 ASIA-PACIFIC TOPICAL SKIN ADHESIVES MARKET, BY PRODUCT TYPE 43
8.1 OVERVIEW 44
8.2 CYANOACRYLATE 47
8.2.1 2-OCTYL CYANOACRYLATE ADHESIVE 47
8.2.2 N-BUTYL CYANOACRYLATE ADHESIVE 47
8.2.3 2-ETHYL CYANOACRYLATE ADHESIVE 47
8.2.4 M-ETHYL CYANOACRYLATE ADHESIVE 48
8.2.5 OTHERS 48
8.3 METHYLIDENE MALONATE 48
8.4 OTHERS 48
9 ASIA-PACIFIC TOPICAL SKIN ADHESIVES MARKET, BY APPLICATION 49
9.1 OVERVIEW 50
9.2 WOUND CLOSURE 53
9.2.1 MINIMAL INVASIVE SURGERY 53
9.2.2 LONG SURGICAL INCISIONS 54
9.3 TRAUMA INDUCED LACERATIONS 54
9.4 BURN AND SKIN GRAFTING 54
10 ASIA-PACIFIC TOPICAL SKIN ADHESIVES MARKET, BY END USER 55
10.1 OVERVIEW 56
10.2 HOSPITALS 59
10.3 TRAUMA CENTERS 59
10.4 AMBULATORY SURGICAL CENTERS 59
10.5 CLINICS 60
10.6 OTHERS 60
11 ASIA-PACIFIC TOPICAL SKIN ADHESIVES MARKET, BY DISTRIBUTION CHANNEL 61
11.1 OVERVIEW 62
11.2 DIRECT TENDER 65
11.3 RETAIL SALES 65
11.4 OTHERS 65
12 ASIA PACIFIC 66
12.1 JAPAN 71
12.2 CHINA 73
12.3 SOUTH KOREA 75
12.4 INDIA 77
12.5 AUSTRALIA 79
12.6 SINGAPORE 81
12.7 THAILAND 83
12.8 MALAYSIA 85
12.9 INDONESIA 87
12.10 PHILIPPINES 89
12.11 VIETNAM 91
12.12 REST OF ASIA-PACIFIC 93
13 ASIA-PACIFIC TOPICAL SKIN ADHESIVE MARKET: COMPANY LANDSCAPE 94
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 94
14 SWOT ANALYSIS 95
15 COMPANY PROFILE 96
15.1 JOHNSON & JOHNSON SERVICES, INC. 96
15.1.1 COMPANY SNAPSHOT 96
15.1.2 REVENUE ANALYSIS 96
15.1.3 PRODUCT PORTFOLIO 97
15.1.4 RECENT DEVELOPMENT 97
15.2 ADVANCED MEDICAL SOLUTIONS GROUP PLC 98
15.2.1 COMPANY SNAPSHOT 98
15.2.2 REVENUE ANALYSIS 98
15.2.3 PRODUCT PORTFOLIO 99
15.2.4 RECENT DEVELOPMENT 99
15.3 CARDINAL HEALTH. 100
15.3.1 COMPANY SNAPSHOT 100
15.3.2 REVENUE ANALYSIS 100
15.3.3 PRODUCT PORTFOLIO 101
15.3.4 RECENT DEVELOPMENT 101
15.4 3M 102
15.4.1 COMPANY SNAPSHOT 102
15.4.2 REVENUE ANALYSIS 102
15.4.3 PRODUCT PORTFOLIO 103
15.4.4 RECENT DEVELOPMENT 103
15.5 MEDTRONIC 104
15.5.1 COMPANY SNAPSHOT 104
15.5.2 REVENUE ANALYSIS 104
15.5.3 PRODUCT PORTFOLIO 105
15.5.4 RECENT DEVELOPMENT 105
15.6 ALFA PHARMA GMBH 106
15.6.1 COMPANY SNAPSHOT 106
15.6.2 PRODUCT PORTFOLIO 106
15.6.3 RECENT DEVELOPMENTS 106
15.7 B. BRAUN MELSUNGEN AG 107
15.7.1 COMPANY SNAPSHOT 107
15.7.2 PRODUCT PORTFOLIO 107
15.7.3 RECENT DEVELOPMENT 107
15.8 CHEMENCE 108
15.8.1 COMPANY SNAPSHOT 108
15.8.2 PRODUCT PORTFOLIO 108
15.8.3 RECENT DEVELOPMENTS 108
15.9 DUPONT 109
15.9.1 COMPANY SNAPSHOT 109
15.9.2 REVENUE ANALYSIS 109
15.9.3 PRODUCT PORTFOLIO 110
15.9.4 RECENT DEVELOPMENT 110
15.10 E-XCLUSIF MEDICAL SUPPLY PTE LTD 111
15.10.1 COMPANY SNAPSHOT 111
15.10.2 PRODUCT PORTFOLIO 111
15.10.3 RECENT DEVELOPMENTS 111
15.11 GLUSTITCH 112
15.11.1 COMPANY SNAPSHOT 112
15.11.2 PRODUCT PORTFOLIO 112
15.11.3 RECENT DEVELOPMENTS 112
15.12 LIFEHEALTHCARE 113
15.12.1 COMPANY SNAPSHOT 113
15.12.2 PRODUCT PORTFOLIO 113
15.12.3 RECENT DEVELOPMENTS 113
15.13 MEDLINE INDUSTRIES, INC. 114
15.13.1 COMPANY SNAPSHOT 114
15.13.2 PRODUCT PORTFOLIO 114
15.13.3 RECENT DEVELOPMENT 114
15.14 NISSHA MEDICAL TECHNOLOGIES 115
15.14.1 COMPANY SNAPSHOT 115
15.14.2 PRODUCT PORTFOLIO 115
15.14.3 RECENT DEVELOPMENTS 115
15.15 SURGITECH INNOVATION 116
15.15.1 COMPANY SNAPSHOT 116
15.15.2 PRODUCT PORTFOLIO 116
15.15.3 RECENT DEVELOPMENT 116
15.16 VYGON 117
15.16.1 COMPANY SNAPSHOT 117
15.16.2 PRODUCT PORTFOLIO 117
15.16.3 RECENT DEVELOPMENT 117
16 QUESTIONNAIRE 118
17 RELATED REPORTS 120

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.